biosimilar erythropoietin

· Shenyang Sunshine Pharmaceutical Co., LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for biosimilar erythropoietin, covering 2020-10-22 to 2022-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) [Phase 3]